Forecasting the Performance Outcome of Clinical Trials Using Model-Based Earned Value Performance Analysis (MB-EVPA™) as a Method

Performance evaluation has become an increasingly important issue in
the pharmaceutical industry. Only a few concepts and approaches are
really suitable to describe what is going on. Among these, earned-value
performance analysis (EVPA) was introduced into performance
monitoring of development projects and individual work packages, such
as clinical trials.